Sherry Rotunda, MD
MOHS-Micrographic Surgery · Oceanside, CANPI 1154355097
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 256 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations.
Across 256 payments — averaging $21.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$583
- LEO Pharma Inc.$511
- Sun Pharmaceutical Industries Inc.$390
- E.r. Squibb & Sons, L.L.C.$362
- Pfizer$354
- plus $2K from 26 others
Across 27 payments — averaging $3467.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$65K
- GSK$25K
- Sanofi Pasteur Inc.$4K
What the payments were for
- Food & beverage$5,42497%
- Education$1903%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 53 | $1,011 |
| Johnson & Johnson | 24 | $583 |
| LEO Pharma Inc. | 29 | $511 |
| Sun Pharmaceutical Industries Inc. | 20 | $390 |
| E.r. Squibb & Sons, L.L.C. | 13 | $362 |
| Pfizer | 19 | $354 |
| UCB, Inc. | 9 | $299 |
| Regeneron Healthcare Solutions, Inc. | 9 | $275 |
| Novartis | 13 | $257 |
| Galderma Laboratories, L.p. | 10 | $229 |
| Incyte Corporation | 4 | $204 |
| Sanofi | 8 | $170 |
| Revance Therapeutics, Inc. | 7 | $132 |
| Janssen Scientific Affairs, LLC | 1 | $119 |
| Biofrontera Inc. | 6 | $100 |
| Arcutis Biotherapeutics, Inc. | 5 | $94 |
| Amgen | 4 | $81 |
| Almirall LLC | 3 | $62 |
| Argenx US, Inc. | 1 | $57 |
| Dermira, Inc. | 2 | $42 |
| Helsinn Therapeutics (U.S.), Inc. | 3 | $41 |
| Lilly USA, LLC | 2 | $34 |
| Krystal Biotech Inc | 1 | $28 |
| Bristol Myers Squibb | 1 | $24 |
| Boehringer Ingelheim | 1 | $24 |
| Organon | 2 | $23 |
| Kyowa Kirin, Inc. | 1 | $20 |
| Botanix SB Inc | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Sientra, Inc. | 1 | $18 |
| Mission Pharmacal Company | 1 | $17 |
| Strata Skin Sciences, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,614 in reported general payments places this provider in the 70th percentile of 144 mohs-micrographic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Unoready PenSecukinumab | 11 | $78,043 |
| Fluorouracil | 87 | $5,745 |
| Ketoconazole | 125 | $2,208 |
| Clobetasol Propionate | 45 | $1,764 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 62 | $1,109 |
| Mupirocin | 84 | $754 |
| Finasteride | 34 | $638 |
| Metronidazole | 15 | $586 |
| CiclopiroxCiclopirox Olamine | 18 | $584 |
| ValacyclovirValacyclovir Hcl | 27 | $535 |
| Doxycycline Hyclate | 36 | $535 |
| Imiquimod | 13 | $469 |
| Triamcinolone Acetonide | 45 | $466 |
| Dutasteride | 15 | $461 |
| Nitro-BidNitroglycerin | 12 | $421 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Oceanside
- Susan ShimomayeOceanside$13K
- Robert ScheinbergOceanside$10K
- Alice LiuOceanside$6K
- Sarah ArronBurlingame$98K
- Daniel Zelacla Jolla$43K
- Ralph MasseySanta Monica$38K
- Michael MortazieOrange$29K
- Sumaira AasiStanford$27K
- Andrea WilleySacramento$21K
- Benjamin Kelleyla Jolla$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.